Financial Performance Overview

The company reported a significant financial turnaround in Q2 FY26-27, returning to profitability after reporting a loss in the previous quarter.

Revenue Performance:

  • Q2 FY25-26 Revenue: ₹11,793 lakhs
  • Q1 FY26-27 Revenue: ₹12,599 lakhs (6.8% growth YoY)
  • Q2 FY26-27 Revenue: ₹12,979 lakhs (3.0% growth QoQ and 10.1% growth YoY)
  • Q2 FY26-27 revenue represents the highest level across the three quarters shown

Profitability Metrics:

  • Q2 FY26-27 EBITDA: ₹466 lakhs (compared to ₹59 lakhs in Q1 FY26-27 and ₹396 lakhs in Q2 FY25-26)
  • Q2 FY26-27 PBT: ₹212.94 lakhs (compared to loss of ₹145 lakhs in Q1 FY26-27)
  • Q2 FY26-27 PAT: Approximately ₹190 lakhs (reversing previous quarter's loss)

Operational Metrics

Production Volume:

  • Q2 FY25-26: 498 MT
  • Q1 FY26-27: 551 MT
  • Q2 FY26-27: 545 MT

Sales Volume:

  • Q2 FY25-26: 5,584 MT
  • Q1 FY26-27: 5,217 MT
  • Q2 FY26-27: 5,780.9 MT

Challenges Faced

The presentation highlights three main challenges affecting performance:

1. Very Low Demand: Lower demand impacted revenue generation and capacity utilization, contributing to Q1 loss

2. Raw Material Price Hike: Rising raw material costs due to MIP (Minimum Import Price) impacted pricing, sales realization and profit margins

3. Dollar Price Instability: Exchange-rate volatility increased uncertainty around imported raw material costs and margins

Company Mission and Strategy

The company aims to become one of India's leading API and pharmaceutical intermediate manufacturers through innovation, operational excellence, and responsible manufacturing. The strategy emphasizes collaboration, safety, R&D, quality, and sustainable practices to meet evolving customer and regulatory requirements.

Capital Structure and Market Data

Shareholding Pattern (as on 30th September 2026):

  • Promoter and Promoter Group: 63.39%

Market Indicators (as on 27th October 2026):

  • Listed on: BSE
  • Issued Shares: 5,36,15,500
  • Share Price: ₹34.00
  • Paid up Capital: ₹5361.55 lakhs
  • 52 Weeks High/Low: ₹60.95/₹28.82

Forward-Looking Statements

The presentation contains forward-looking statements regarding the company's market opportunity and business prospects, subject to known and unknown risks, uncertainties, and assumptions that are difficult to predict. The company assumes no obligation to update any forward-looking information.

Disclaimer

The presentation makes no representation or warranty regarding the truth, accuracy, reliability, or fairness of the contents and may not be all-inclusive. Any liability in respect of the contents or any omission is expressly excluded.